Crossmark

The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft

Crossref DOI link: https://doi.org/10.1038/s41409-021-01334-6

Published Online: 2021-05-18

Published Print: 2021-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Beauverd, Yan

Morin, Sarah

Stephan, Caroline

De Ramon Ortiz, Carmen

Fabra Urdiola, Marta

Giannotti, Federica

Mahne, Elif

Mamez, Anne-Claire

Mappoura, Maria

Simonetta, Federico

Tran, Thien-An

Ayer, Christian

Noetzlin, Sarah

Verdon, Isaline

Masouridi-Levrat, Stavroula https://orcid.org/0000-0001-7502-5454
Chalandon, Yves https://orcid.org/0000-0001-9341-8104
License Information

Text and Data Mining valid from 2021-05-18

Version of Record valid from 2021-05-18
More Information

Article History

Received: 28 January 2021

Revised: 28 April 2021

Accepted: 5 May 2021

First Online: 18 May 2021

Compliance with ethical standards

:

: The authors declares no competing interests.

Document is current

Any future updates will be listed below